Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electrophysiologic Changes After Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration

NCT00539734 is registered in ClinicalTrials.gov with Prince of Songkla University as lead sponsor.

NCT NCT00539734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00539734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electrophysiologic Changes After Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration
Lead sponsor
Prince of Songkla University
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2007
Completion date
February 28, 2009
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration